Fact CheckerSign in

NCT07614204Active, not recruiting

Educational Intervention for Patients Undergoing Surgery for Lung Cancer

The Impact of an Educational Intervention on Disease Acceptance, Quality of Life, Pain Levels, and Postoperative Clinical and Biometric Outcomes Among Patients Undergoing Surgery for Lung Cancer.

Source: ClinicalTrials.gov · Last updated 29 May 2026

Brief summary (registry, in English)

The goal of this interventional study is to learn about the effect of a structured educational intervention in patients undergoing surgery for lung cancer. The study will examine whether this intervention can improve patients' acceptance of the disease, quality of life, pain levels, and postoperative clinical and biometric outcomes. The main question it aims to answer is: Does a structured educational intervention improve disease acceptance, quality of life, pain levels, and postoperative clinical and biometric outcomes in patients undergoing surgery for lung cancer? Participants are assigned to two groups. Participants in the intervention group receive a structured educational intervention in addition to usual care, while participants in the control group receive usual care only. Data are collected through questionnaires and clinical and biometric measurements after surgery, with follow-up assessments over a 5-year period.

Status (registry)
Active, not recruiting
Study type
Interventional
Enrollment
160 (actual)
First submitted
1 May 2026
Start date
1 Jan 2021
Primary completion date
1 Jan 2028
Lead sponsor
National and Kapodistrian University of Athens
Diseases
Lung cancer
NCT number
NCT07614204

What you commit to

  • Study type: Interventional
  • Participants enrolled: 160
  • From 1 Jan 2021 to the primary completion date, 1 Jan 2028
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Presence of a chronic condition affecting behavior or ability to cooperate with the study procedures.

Other

  • Inability to provide written informed consent.
  • Inability to speak, understand, or read the Greek language.
  • Impaired level of consciousness that prevents cooperation.
  • Lack of a supportive psychosocial network.
  • Inability to cooperate with the medical and nursing staff.
  • Inability to participate in the interview process or complete the required study assessments.

Who the study is looking for

  • Patients diagnosed with lung cancer.
  • Patients admitted to the referral hospital and undergoing surgical treatment for lung cancer.
  • Age older than 18 years.
  • Signed written informed consent.
  • Ability to speak, understand, and read the Greek language.
  • Undisturbed level of consciousness allowing cooperation with the researcher and the healthcare team.
  • Ability to participate in a personal interview and complete the study questionnaires.
  • Availability of a supportive psychosocial network/caregiver, where required for participation in the educational intervention.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
General University Hospital "ATTIKON"
Coordinator of this site? Confirm its status
ChaïdáriGreeceUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.